Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
SRF Limited is a chemical-based multi-business entity specializing in industrial and specialty intermediates, with a global footprint across 100+ countries.
For Q3 FY26, SRF reported a 6.3% increase in gross operating revenue and a 22% increase in EBIDTA year-over-year, reflecting strong performance amidst global uncertainties.
The Chemicals Business, particularly in Fluorochemicals, recorded a robust 22% growth in revenue due to higher refrigerant volumes and operational efficiencies.
Amid intense competition, SRF is heavily investing in R&D and capacity expansion, including a new Pharma Intermediates Plant in Dahej to boost growth in its specialty chemicals division.
SRF's focus on sustainable and innovative products like low-GWP refrigerants and value-added films demonstrates its commitment to long-term competitiveness and environmental responsibility.
Chemicals & Petrochemicals
Commodity Chemicals
79,860 Cr
High Risk
43.5
42.4
1.2
5.7
3,319.00
2,313.75
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockSRF Ltd (SRF) is currently trading at 2,731.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
SRF Limited is a chemical-based multi-business entity specializing in industrial and specialty intermediates, with a global footprint across 100+ countries. For Q3 FY26, SRF reported a 6.3% increase in gross operating revenue and a 22% increase in EBIDTA year-over-year, reflecting strong performance amidst global uncertainties. The Chemicals Business, particularly in Fluorochemicals, recorded a robust 22% growth in revenue due to higher refrigerant volumes and operational efficiencies. Amid intense competition, SRF is heavily investing in R&D and capacity expansion, including a new Pharma Intermediates Plant in Dahej to boost growth in its specialty chemicals division. SRF's focus on sustainable and innovative products like low-GWP refrigerants and value-added films demonstrates its commitment to long-term competitiveness and environmental responsibility.
Over the past 52 weeks, SRF Ltd has traded between a low of ₹2,313.75 and a high of ₹3,319.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
SRF Ltd has a market capitalization of approximately 79,859.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
SRF Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 43.52 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 79,859.81 Cr, SRF Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
SRF Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of SRF Ltd is 43.52. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
SRF reported Q4 FY26 net profit/PAT of ₹582 crore (up about 10.6% to 11% YoY) and revenue of ₹4,615 crore (up 7% YoY).
SRF reported consolidated net profit of Rs 582.02 crore for the quarter ended March, up from Rs 526.06 crore a year earlier.
SRF reported Q4 FY26 net profit of ₹582 crore, up 10.6% year-on-year from ₹526 crore.
The 'Biopharma Shakti' scheme is a major positive, as it provides a ₹10,000 crore ecosystem boost that directly supports SRF's strategic diversification into high-value pharma intermediates.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
2494.35 | 79,860 Cr | 43.52 | 5.69 | 0.00 | 13.07 | 13.18 | 7.60 | ||
652.60 | 19,580 Cr | -10.33 | 0.92 | 1.26 | -0.92 | 3.67 | -4.39 | ||
1228.05 | 16,015 Cr | 18.30 | 2.46 | 0.79 | 15.11 | 14.77 | 5.84 | ||
439.40 | 7,194 Cr | 11.55 | 0.83 | 3.68 | 7.35 | 9.24 | 5.66 | ||
716.50 | 5,077 Cr | -592.45 | 0.91 | 2.29 | 0.00 | 0.84 | -0.10 | ||
2052.40 | 4,331 Cr | 61.75 | 11.61 | 0.10 | 18.80 | 20.80 | 13.29 | ||
512.15 | 4,320 Cr | 9.14 | 1.22 | 2.55 | 13.30 | 17.92 | 10.99 | ||
| Median: 7 Co. | — | 716.50 | 7,194 Cr | 11.55 | 1.22 | 1.26 | 13.07 | 13.18 | 5.84 |
